Nephros (NEPH) SEC Filings & 10K Form $1.59 +0.05 (+3.25%) (As of 11/20/2024 ET) Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Recent Nephros SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView11/14/20243:03 PMNephros (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 11/13/20243:15 PMNephros (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 06/17/20244:18 PMNephros (Filer)Form S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans 05/30/20243:35 PMAmron Arthur H (Reporting)Nephros (Issuer)Form 4Statement of changes in beneficial ownership of securities 05/24/20243:05 PMNephros (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/23/202411:15 PMNephros (Filer)Form EFFECT05/16/20243:29 PMAmron Arthur H (Reporting)Nephros (Issuer)Form 4Statement of changes in beneficial ownership of securities 05/01/20247:00 AMNephros (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/12/20243:10 PMNephros (Filer)Form ARS04/12/20243:10 PMNephros (Filer)Form ARS03/14/20243:43 PMDAVIDSON CHARLES E (Reporting)JACOBS JOSEPH (Reporting)Nephros (Issuer)WEXFORD CAPITAL LP (Reporting)Wexford GP LLC (Reporting)Form 4Statement of changes in beneficial ownership of securities 12/15/20233:48 PMNephros (Issuer)Spandow Oliver J. (Reporting)Form 4Statement of changes in beneficial ownership of securities 12/15/20233:47 PMAmron Arthur H (Reporting)Nephros (Issuer)Form 4Statement of changes in beneficial ownership of securities 12/15/20233:48 PMHarris Joseph Michael (Reporting)Nephros (Issuer)Form 4Statement of changes in beneficial ownership of securities 12/15/20233:48 PMLask Alisa (Reporting)Nephros (Issuer)Form 4Statement of changes in beneficial ownership of securities 12/11/20233:17 PMBanks Robert R. Jr. (Reporting)Nephros (Issuer)Form 4Statement of changes in beneficial ownership of securities (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies Lucid Diagnostics SEC Filings Alpha Pro Tech SEC Filings Nutriband SEC Filings Apyx Medical SEC Filings Cytosorbents SEC Filings Nexalin Technology SEC Filings CollPlant Biotechnologies SEC Filings Milestone Scientific SEC Filings Bellevue Life Sciences Acquisition SEC Filings Envoy Medical SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:NEPH) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nephros, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nephros With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
